Form 4 for AIM AIM ImmunoTech Inc.
Accepted 2025-04-04 00:00:00 ET · period of report 2025-04-04 · accession 0001641172-25-002827 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-04 | 2025-04-04 | AIM | Rodino Peter W III | COO, Sec, Gen. Counsel | P - Purchase | $0.09 | +500 | 401.8K | +0.1% | +$45 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-04 | P | A | 500 | $0.09 | 401,762 | D | — | — |